CICR-NAM (Nicotinamide)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CICR-NAM (Nicotinamide), covering 2024-11-06 to 2024-11-06. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients with Mild to Moderately Active Ulcerative Colitis [Phase 2, Phase 3]